(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 40.18%1.82B | 31.47%1.79B | 23.19%4.46B | -87.86%234.14M | 25.00%1.57B | 46.72%1.3B | 19.60%1.36B | -36.99%3.62B | 25.94%1.93B | -17.22%1.25B |
Total premiums earned | 26.63%1.4B | 16.23%1.26B | 10.62%3.31B | -108.51%-117.96M | 14.59%1.24B | 8.93%1.1B | 7.48%1.09B | -42.84%3B | 2.53%1.39B | -15.51%1.09B |
-Net premiums written | 26.63%1.4B | 16.23%1.26B | 9.72%2.9B | -138.53%-534.18M | 14.59%1.24B | 8.93%1.1B | 7.48%1.09B | -49.78%2.64B | 2.53%1.39B | -15.51%1.09B |
-Increase decrease in net unearned premium reserves | ---- | ---- | 17.33%416.22M | ---- | ---- | ---- | ---- | 2,010.53%354.75M | ---- | ---- |
Net investment income | 457.40%121.67M | 464.26%212.4M | 196.81%227.35M | -322.90%-145.44M | -95.63%256K | -2,279.04%-34.04M | 3,239.53%37.64M | 3.58%-234.83M | 246.89%65.25M | 113.85%5.85M |
Net realized gain loss on investments | 996.76%74.96M | 553.96%62.17M | 107.01%2.36M | 91.06%-610K | 501.72%185.72M | 96.60%-8.36M | 827.95%9.51M | -97.87%1.14M | -114.42%-6.82M | 239.96%30.87M |
Net trading income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 627.01%253.58M | ---- |
Fees and commission income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -60.67%7.41M | ---- |
Total interest income | -4.24%230.01M | 10.59%249.68M | 6.67%912.15M | 120.95%498.14M | 4.26%136.53M | 97.87%240.2M | 75.93%225.77M | 9.29%855.08M | 15.79%225.46M | -33.79%130.95M |
Other income expense | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -118.17%-2.05M | --0 |
Total expenses | 48.31%1.6B | 36.30%1.54B | 27.54%3.5B | -100.31%-5.23M | 24.16%1.3B | 59.91%1.08B | 22.38%1.13B | -46.37%2.74B | 24.12%1.66B | -22.49%1.05B |
Policy acquisition expense | ---- | 18.97%319.52M | 10.09%496.87M | ---423.15M | 29.47%361.62M | ---- | --268.58M | 6,125.26%451.35M | ---- | --279.3M |
Net policyholder benefits and claims | 32.36%1.23B | 23.39%688.1M | 11.82%3.33B | 80.69%1.46B | 3.14%673.01M | 26.77%932.34M | -31.96%557.69M | 36.32%2.98B | 27.69%805.43M | 20.79%652.53M |
Change in insurance liabilities, net of reinsurance | 195.52%322.86M | 93.03%498.58M | 42.21%-495.41M | -355.70%-1.09B | 211.83%228.07M | 209.44%109.25M | 296.10%258.28M | -162.78%-857.25M | 43.01%426.68M | -82.63%73.14M |
Fees and commission expense | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | 4.85%206.45M | ---- |
Staff costs | ---- | ---- | -1.08%89.11M | ---- | ---- | ---- | ---- | -72.56%90.08M | ---- | ---- |
Selling and administrative expenses | ---- | ---- | 10.21%19.23M | ---- | ---- | ---- | ---- | -33.24%17.45M | 1.22%193.1M | ---- |
-Selling and marketing expense | ---- | ---- | 8.28%18.5M | ---- | ---- | ---- | ---- | -29.36%17.08M | ---- | ---- |
-General and administrative expense | ---- | ---- | 101.10%732K | ---- | ---- | ---- | ---- | -81.32%364K | 1.22%193.1M | ---- |
Rent and land expenses | ---- | ---- | -7.62%412K | ---- | ---- | ---- | ---- | -53.20%446K | ---- | ---- |
Depreciation and amortization | ---- | ---- | -17.27%17.07M | ---- | ---- | ---- | ---- | -64.40%20.63M | ---- | ---- |
-Depreciation | ---- | ---- | -52.72%3.53M | ---- | ---- | ---- | ---- | -77.65%7.46M | ---- | ---- |
-Amortization | ---- | ---- | 2.82%13.54M | ---- | ---- | ---- | ---- | -46.41%13.17M | ---- | ---- |
Other operating expenses | 14.40%40.95M | -30.51%29.04M | -1.87%43.25M | -342.30%-72.33M | -8.82%41.39M | -6.08%35.79M | 17.73%41.79M | -86.50%44.08M | 37.56%29.85M | 140.54%45.39M |
Special income (charges) | ---- | ---- | ---60K | ---- | ---- | ---- | ---- | ---- | --76K | ---- |
-Less:Impairment of capital assets | ---- | ---- | --60K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Less:Other special charges | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---76K | ---- |
Net non-operating interest income (expenses) | ---- | ---- | 48.00%-39K | ---- | ---- | ---- | ---- | 99.56%-75K | 21.98%-142K | ---- |
-Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -21.98%142K | ---- |
-Total other finance cost | ---- | ---- | -48.00%39K | ---- | ---- | ---- | ---- | -99.53%75K | ---- | ---- |
Income before tax | 0.86%224.79M | 8.05%250.98M | 9.52%956.89M | -10.51%239.36M | 29.36%262.36M | 4.88%222.88M | 7.77%232.29M | 39.67%873.73M | 38.57%267.48M | 27.64%202.82M |
Income tax | 2.79%57.77M | 2.60%61.15M | -13.10%225.98M | -54.84%45.67M | 2.01%64.5M | -9.96%56.2M | -8.30%59.6M | 76.80%260.06M | 163.73%101.14M | 44.53%63.23M |
Net income | 0.21%167.02M | 9.93%189.83M | 19.10%730.91M | 16.44%193.69M | 41.74%197.86M | 11.06%166.67M | 14.71%172.69M | 28.25%613.67M | 7.54%166.34M | 21.22%139.59M |
Net income continuous operations | 0.21%167.02M | 9.93%189.83M | 19.10%730.91M | 16.44%193.69M | 41.74%197.86M | 11.06%166.67M | 14.71%172.69M | 28.25%613.67M | 7.54%166.34M | 21.22%139.59M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 0.21%167.02M | 9.93%189.83M | 19.10%730.91M | 16.44%193.69M | 41.74%197.86M | 11.06%166.67M | 14.71%172.69M | 28.25%613.67M | 7.54%166.34M | 21.22%139.59M |
Preferred stock dividends | -15.87%53.5M | 18.23%202.89M | 96.86%63.59M | 34.67%171.6M | 9.32%139.3M | |||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 10.12%113.52M | 9.93%189.83M | 19.44%528.02M | -134.03%-9.2M | 41.74%197.86M | -12.48%103.08M | 14.71%172.69M | 25.92%442.07M | -0.79%27.04M | 21.22%139.59M |
Gross dividend payment | ||||||||||
Basic earnings per share | ||||||||||
Diluted earnings per share | ||||||||||
Dividend per share | ||||||||||
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data